Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer

NCT01196741 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

107

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Paclitaxel
DRUG: Saracatinib
DRUG: Matched placebo

Sponsor

University College, London

Collaborators

[object Object]
[object Object]